Every material Form 8-K SUJA LIFE, INC. has filed with the SEC since August 04, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Suja Life increased its Board from seven to nine members and appointed Robert B. Engel and Zahir Ibrahim as directors effective October 16, 2026. Engel also joined the Audit Committee, and both were designated by affiliates of Paine Schwartz Partners, LLC, the Company's principal stockholder. The filing describes the appointments as adding financial, accounting and capital markets expertise, but it discloses no financial results or guidance.
Board expanded from seven to nine members; Engel and Ibrahim appointed effective October 16, 2026
Engel, former CEO of CoBank, joins the Audit Committee; Ibrahim is a former CFO of BARK, Annie's and KIND
Both directors were designated by affiliates of Paine Schwartz Partners, LLC under a Director Designation Agreement dated May 8, 2026
Each receives a $75,000 annual cash retainer and a $100,000 grant-date-value RSU award, prorated for service time
Suja Life entered an Amended and Restated Credit Agreement on August 20, 2026, with JPMorgan Chase Bank, N.A. as administrative agent, replacing its August 23, 2021 credit agreement. The main change is a lower interest rate, and the company expects its 2026 total interest expense to improve to $18.0 million; the CFO said the deal adds no new debt.
Interest rate is Term SOFR plus 1.75%, 2.00%, or 2.25% per annum, based on the consolidated net leverage ratio
Company expects 2026 total interest expense to improve to $18.0 million
CFO Jeff Pedersen said the transaction does not add debt and reduces the cost of carrying existing debt
Agreement dated August 20, 2026, between indirect subsidiaries and JPMorgan Chase Bank, N.A.
Suja Life reported second-quarter 2026 net sales of $83.9 million, up 11.6%, and Adjusted EBITDA of $14.6 million, up 50.0%. The net loss widened to $27.8 million, which includes $25.1 million of one-time IPO-related transaction costs, and the company updated its fiscal 2026 outlook, citing near-term softness in the grocery channel.
Q2 net sales rose 11.6% to $83.9 million from $75.2 million; gross profit margin was 46.7% versus 47.4%.
Net loss was $27.8 million versus $5.7 million a year earlier, including $25.1 million of IPO-related transaction costs and a $2.3 million loss on debt extinguishment.
FY2026 outlook: net sales of $360 million to $369 million and Adjusted EBITDA of $70 million to $72 million; the company said the Adjusted EBITDA range is consistent with prior expectations.
As of June 29, 2026, cash was $20.6 million and total debt was $163.0 million, versus $303.9 million at December 29, 2025; the company is pursuing a refinancing that it says would not add leverage.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every SUJA LIFE, INC. filing is on SEC EDGAR ↗. 8-K briefs of other companies →